Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Can J Physiol Pharmacol ; 101(10): 502-508, 2023 Oct 01.
Article in English | MEDLINE | ID: mdl-37463517

ABSTRACT

Cardiac surgery-associated acute kidney injury is a common post-operative complication, mostly due to increasing oxidative stress. Recently, molecular hydrogen (H2 gas) has also been applied to cardiac surgery due to its ability to reduce oxidative stress. We evaluated the potential effect of H2 application on the kidney in an in vivo model of simulated heart transplantation. Pigs underwent cardiac surgery within 3 h while connected to extracorporeal circulation (ECC) and subsequent 60 min of spontaneous reperfusion of the heart. We used two experimental groups: T-pigs after transplantation and TH-pigs after transplantation treated with 4% H2 mixed with air during inhalation of anesthesia and throughout oxygenation of blood in ECC. The levels of creatinine, urea and phosphorus were measured in plasma. Renal tissue samples were analyzed by Western blot method for protein levels of nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap-1), and superoxide dismutase (SOD1). After cardiac surgery, selected plasma biomarkers were elevated. However, H2 therapy was followed by the normalization of all these parameters. Our results suggest activation of Nrf2/Keap1 pathway as well as increased SOD1 protein expression in the group treated with H2. The administration of H2 had a protective effect on the kidneys of pigs after cardiac surgery, especially in terms of normalization of plasma biomarkers to control levels.


Subject(s)
Acute Kidney Injury , Cardiac Surgical Procedures , Animals , Swine , Kelch-Like ECH-Associated Protein 1/metabolism , NF-E2-Related Factor 2/metabolism , Oxidative Stress , Kidney , Acute Kidney Injury/drug therapy , Acute Kidney Injury/etiology , Acute Kidney Injury/prevention & control , Superoxide Dismutase/metabolism , Cardiac Surgical Procedures/adverse effects , Hydrogen/pharmacology , Hydrogen/therapeutic use , Hydrogen/metabolism , Biomarkers/metabolism
2.
Mol Cell Endocrinol ; 518: 110924, 2020 12 01.
Article in English | MEDLINE | ID: mdl-32619581

ABSTRACT

Oxytocin has been suggested as a potential therapeutic agent in autism and other neuropsychiatric conditions. Although, the link between the deficit in "SH3 domain and ankyrin repeat containing protein 3" (SHANK3) and autism spectrum disorders is highly studied topic, developmental mechanisms are still poorly understood. In this study, we clearly confirm that SHANK3 deficiency is accompanied with abnormalities in neurite number and length, which are reversed by oxytocin treatment (1 µM, 48h) in primary hippocampal neurons. Transient silencing for the SHANK3 gene (siSHANK3) in neuron-like cell line (SH-SY5Y) revealed a significant decrease in the expression levels of Neurexins 1α, 1ß, 2α and 2ß. Oxytocin treatment compensated reduced levels of Synapsin I, PSD95 and Neuroligin 3 in siSHANK3 cells suggesting a marked potential of oxytocin to ameliorate defects present in conditions of SHANK3 deficiency. Further analysis of hippocampal tissue revealed that oxytocin application (0.1 µg/µl, s.c. at P2 and P3 day) affects levels of synaptic proteins and GTPases in both WT and SHANK3 deficient mice on day P5. Oxytocin stimulated the mRNA expression of RhoB and Rac1 in both WT and SHANK3 deficient mice. Our data suggest that autism relevant synaptic pathologies could be reversed by oxytocin treatment.


Subject(s)
Autistic Disorder , Microfilament Proteins/genetics , Nerve Tissue Proteins/genetics , Neurons/drug effects , Oxytocin/pharmacology , Animals , Animals, Newborn , Autistic Disorder/genetics , Autistic Disorder/metabolism , Autistic Disorder/pathology , Cells, Cultured , Disease Models, Animal , Female , Gene Expression/drug effects , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Neurites/drug effects , Neurites/metabolism , Neurites/pathology , Neurons/metabolism , Neurons/pathology , Neuroprotection/drug effects , Neuroprotection/genetics , Receptors, Neurotransmitter/genetics , Receptors, Neurotransmitter/metabolism
3.
Molecules ; 25(12)2020 Jun 23.
Article in English | MEDLINE | ID: mdl-32585916

ABSTRACT

We have investigated the vasoactive effects of the coupled nitro-sulfide signaling pathway in lobar arteries (LAs) isolated from the nephrectomized kidneys of cancer patients: normotensive patients (NT) and patients with arterial hypertension (AH). LAs of patients with AH revealed endothelial dysfunction, which was associated with an increased response to the exogenous NO donor, nitrosoglutathione (GSNO). The interaction of GSNO with the H2S donor triggered a specific vasoactive response. Unlike in normotensive patients, in patients with AH, the starting and returning of the vasorelaxation induced by the end-products of the H2S-GSNO interaction (S/GSNO) was significantly faster, however, without the potentiation of the maximum. Moreover, increasing glycemia shortened the time required to reach 50% of the maximum vasorelaxant response induced by S/GSNO products so modulating their final effect. Moreover, we found out that, unlike K+ channel activation, cGMP pathway and HNO as probable mediator could be involved in mechanisms of S/GSNO action. For the first time, we demonstrated the expression of genes coding H2S-producing enzymes in perivascular adipose tissue and we showed the localization of these enzymes in LAs of normotensive patients and in patients with AH. Our study confirmed that the heterogeneity of specific nitroso-sulfide vasoactive signaling exists depending on the occurrence of hypertension associated with increased plasma glucose level. Endogenous H2S and the end-products of the H2S-GSNO interaction could represent prospective pharmacological targets to modulate the vasoactive properties of human intrarenal arteries.


Subject(s)
Blood Glucose/metabolism , Hypertension/blood , Hypertension/physiopathology , Nitric Oxide/metabolism , Renal Artery/physiopathology , Signal Transduction , Sulfides/metabolism , Animals , Cystathionine beta-Synthase/genetics , Cystathionine beta-Synthase/metabolism , Cystathionine gamma-Lyase/genetics , Cystathionine gamma-Lyase/metabolism , Female , Gene Expression Regulation, Enzymologic , Glutathione/pharmacology , Humans , Male , Middle Aged , Protein Transport , Rats , Serotonin/pharmacology , Thoracic Arteries/drug effects , Thoracic Arteries/physiopathology , Vasodilation
4.
Mol Cell Biochem ; 457(1-2): 61-72, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30830529

ABSTRACT

microRNAs (miRNAs) constitute a large class of post-transcriptional regulators of gene expression. It has been estimated that miRNAs regulate up to 30% of the protein-coding genes in humans. They are implicated in many physiological and pathological processes, including those involved in radiation-induced heart damage. Biomedical studies indicate that molecular hydrogen has potential as a radioprotective agent due to its antioxidant, anti-inflammatory, and signal-modulating effects. However, the impact of molecular hydrogen on the expression of miRNAs in the heart after irradiation has not been investigated. This study aimed to explore the involvement of miRNA-1, -15b, and -21 in the protective action of molecular hydrogen on rat myocardium damaged by irradiation. The results showed that the levels of malondialdehyde (MDA) and tumor necrosis factor alpha (TNF-α) increased in the rat myocardium after irradiation. Treatment with molecular hydrogen-rich water (HRW) reduced these values to the level of non-irradiated controls. miRNA-1 is known to be involved in cardiac hypertrophy, and was significantly decreased in the rat myocardium after irradiation. Application of HRW attenuated this decrease in all evaluated time periods. miRNA-15b is considered to be anti-fibrotic, anti-hypertrophic, and anti-oxidative. Irradiation downregulated miRNA-15b, whereas administration of HRW restored these values. miRNA-21 is connected with cardiac fibrosis. We observed significant increase in miRNA-21 expression in the irradiated rat hearts. Molecular hydrogen lowered myocardial miRNA-21 levels after irradiation. This study revealed for the first time that the protective effects of molecular hydrogen on irradiation-induced heart damage may be mediated by regulating miRNA-1, -15b, and -21.


Subject(s)
Gamma Rays/adverse effects , Hydrogen/pharmacology , MicroRNAs/metabolism , Myocardium/metabolism , Radiation Injuries, Experimental/metabolism , Radiation Injuries, Experimental/prevention & control , Animals , Male , Myocardium/pathology , Rats , Rats, Wistar
5.
Can J Physiol Pharmacol ; 97(9): 829-836, 2019 Sep.
Article in English | MEDLINE | ID: mdl-30908945

ABSTRACT

Two important aspects of cardiac adaptive response to pregnancy have been studied in normal as well as hypoxic conditions: (1) intercellular signaling mediated by myocardial connexin-43 (Cx43) that is crucial to synchronize heart function; (2) extracellular signaling mediated by matrix metalloproteinase-2 (MMP-2) that is an early marker of extracellular matrix remodeling. Myocardial Cx43 distribution and functional capillary density were determined as well. Hypoxia was induced by exposure of rats to 10.5% O2 and 89.5% N2 in a hermetically sealed chamber. Findings showed that pregnancy resulted in a significant increase of Cx43 protein expression, its functional phosphorylated forms, and enhanced capillary density while did not affect either expression of total MMP-2 or its activity. Maternal hypoxia for 12 or 16 h did not affect elevated Cx43 but enhanced its distribution on lateral sides of the cardiomyocytes. In contrast, hypoxia of nonpregnant rats resulted in upregulation of Cx43, its lateral distribution, and enhanced capillary density. Hypoxia did not affect myocardial MMP-2 either in pregnant or nonpregnant rats. Cardiac adaptive response to pregnancy is accompanied by enhanced Cx43 without changes in MMP-2 signaling. Pregnant rat heart is tolerant to short-term hypoxemia, while nonpregnant rat heart reacts by upregulation of Cx43 and increased capillary density.


Subject(s)
Connexin 43/metabolism , Matrix Metalloproteinase 2/metabolism , Myocardium/cytology , Oxygen/metabolism , Signal Transduction , Animals , Female , Myocardium/metabolism , Pilot Projects , Pregnancy , Rats
6.
Can J Physiol Pharmacol ; 95(10): 1190-1203, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28750189

ABSTRACT

Irradiation of normal tissues leads to acute increase in reactive oxygen/nitrogen species that serve as intra- and inter-cellular signaling to alter cell and tissue function. In the case of chest irradiation, it can affect the heart, blood vessels, and lungs, with consequent tissue remodelation and adverse side effects and symptoms. This complex process is orchestrated by a large number of interacting molecular signals, including cytokines, chemokines, and growth factors. Inflammation, endothelial cell dysfunction, thrombogenesis, organ dysfunction, and ultimate failing of the heart occur as a pathological entity - "radiation-induced heart disease" (RIHD) that is major source of morbidity and mortality. The purpose of this review is to bring insights into the basic mechanisms of RIHD that may lead to the identification of targets for intervention in the radiotherapy side effect. Studies of authors also provide knowledge about how to select targeted drugs or biological molecules to modify the progression of radiation damage in the heart. New prospective studies are needed to validate that assessed factors and changes are useful as early markers of cardiac damage.


Subject(s)
Coronary Vessels/radiation effects , Heart Diseases/etiology , Inflammation Mediators/metabolism , Myocytes, Cardiac/radiation effects , Radiation Injuries/etiology , Reactive Oxygen Species/metabolism , Animals , Apoptosis/radiation effects , Biomarkers/metabolism , Coronary Vessels/metabolism , Coronary Vessels/pathology , DNA Damage , Endothelial Cells/metabolism , Endothelial Cells/pathology , Endothelial Cells/radiation effects , Heart Diseases/metabolism , Heart Diseases/pathology , Humans , Lipid Peroxidation/radiation effects , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , Oxidative Stress/radiation effects , Radiation Injuries/metabolism , Radiation Injuries/pathology , Signal Transduction/radiation effects
7.
Gen Physiol Biophys ; 36(3): 353-359, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28635612

ABSTRACT

The aim of the work was to study the delayed effect of lipopolysaccharide (LPS) administration on endothelial function of the aorta of rats with genetic hypertension. Further, the possibility to ameliorate LPS-induced changes by n-3 polyunsaturated fatty acids (n-3 PUFA) was tested. Rats received a bolus of 1 mg/kg LPS i.p.; n-3 PUFA were administered in the dose of 30 mg/kg daily for 10 days p.o.. Ten days after receiving of LPS, the body weight gain of rats was statistically lower compared to control rats (p < 0.05). n-3 PUFA administration to LPS rats had no effect on this parameter. The TBARS and NAGA concentrations in plasma were significantly increased in the LPS group (p < 0.05) and n-3 PUFA administration returned them to control values. In functional studies, phenylephrine (PE, 1 µmol/l) evoked contraction of aortas which was not statistically different among experimental groups. However, endothelium-dependent relaxation was depressed in the LPS group (p < 0.05) and n-3 PUFA slightly recovered it to control values. In conclusion, oxidative stress seems to be responsible for aortic endothelial dysfunction detected 10 days after administration of LPS to rats. n-3 PUFA slightly improved the function of the endothelium injured by LPS, probably thanks to their antioxidant properties. Prolonged administration of higher doses of n-3 PUFA should defend the vascular endothelium against detrimental effect of bacterial inflammation.


Subject(s)
Aorta/drug effects , Aorta/immunology , Aortitis/chemically induced , Aortitis/immunology , Fatty Acids, Omega-3/administration & dosage , Lipopolysaccharides , Animals , Aortitis/prevention & control , Drug Interactions , Hypertension/immunology , Male , Rats , Rats, Inbred SHR
8.
Nutr Res ; 39: 69-75, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28314639

ABSTRACT

Erythrocyte deformability is an important property of erythrocytes that considerably affects blood flow and hemodynamics. The high content of polyphenols present in dark chocolate has been reported to play a protective role in functionality of erythrocytes. We hypothesized that chocolate might influence erythrocytes not only after repeated chronic intake, but also immediately after its ingestion. Thus, we determined the acute effect of dark chocolate and milk (with lower content of biologically active substances) chocolate intake on erythrocyte deformability. We also focused on selected factors that may affect erythrocyte deformability, specifically nitric oxide production in erythrocytes and total antioxidant capacity of plasma. We determined posttreatment changes in the mentioned parameters 2hours after consumption of chocolate compared with their levels before consumption of chocolate. In contrast to milk chocolate intake, the dark chocolate led to a significantly higher increase in erythrocyte deformability. Nitric oxide production in erythrocytes was not changed after dark chocolate intake, but significantly decreased after milk chocolate. The plasma total antioxidant capacity remained unaffected after ingestion of both chocolates. We conclude that our hypothesis was confirmed. Single ingestion of dark chocolate improved erythrocyte deformability despite unchanged nitric oxide production and antioxidant capacity of plasma. Increased deformability of erythrocytes may considerably improve rheological properties of blood and thus hemodynamics in humans, resulting in better tissue oxygenation.


Subject(s)
Cacao/chemistry , Chocolate , Erythrocyte Deformability/drug effects , Erythrocytes/drug effects , Hemodynamics/drug effects , Plant Preparations/pharmacology , Polyphenols/pharmacology , Adult , Animals , Antioxidants/metabolism , Antioxidants/pharmacology , Diet , Eating , Erythrocytes/physiology , Female , Humans , Male , Milk , Nitric Oxide/blood , Plant Preparations/administration & dosage , Reference Values , Young Adult
9.
Iran J Basic Med Sci ; 19(3): 290-9, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27114799

ABSTRACT

OBJECTIVES: Occludin is essential for proper assembly of tight junctions (TJs) which regulate paracellular endothelial permeability. Omega-3 polyunsaturated fatty acids (Ω-3 PUFA) protect endothelial barrier function against injury. MATERIALS AND METHODS: We examined anti-inflammatory effect of Ω-3 PUFA intake (30 mg/kg/day for 10 days) on expression and location of occludin in the aorta of adult Wistar rats after a single dose of bacterial lipopolysaccharide (LPS, Escherichia coli, 1 mg/kg). The ultrastructure of TJs after LPS administration was also investigated. We measured plasma levels of C-reactive protein (CRP), Malondialdehyde (MDA) and CD68 expression and determined the total activity of NO synthase (NOS) in the aortic tissue. RESULTS: LPS induced a significant decrease of occludin expression accompanied by structural alterations of TJs. Levels of CRP, MDA, CD68 and NOS activity were elevated after LPS injection compared to controls indicating presence of moderate inflammation. Ω-3 PUFA supplementation did not affect occludin expression in treated inflammatory group. However they reduced CRP and MDA concentration and CD68 expression, but conversely, they increased NOS activity compared to inflammatory group. CONCLUSION: Our results indicate that a single dose of LPS could have a long-term impact on occludin expression and thus contribute to endothelial barrier dysfunction. 10-day administration of Ω-3 PUFA had partial anti-inflammatory effects on health of rats without any effect on occludin expression.

10.
Nutr Res ; 33(9): 772-9, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24034577

ABSTRACT

Measurements of enzyme kinetics of renal Na, K-ATPase were used for characterization of ATP- and Na⁺-binding sites in rats that were subjected to 10 days of moderate inflammation that was induced by a single dose of Escherichia coli lipopolysaccharides (LPSs) at a dose of 1 mg kg⁻¹ body weight. We hypothesized that LPSs might initiate a malfunction of renal Na, K-ATPase, which is a key enzyme involved in regulation of sodium homeostasis in the organism. We also investigated the potential effect that fish oil (FO) has in the prevention of Na, K-ATPase alterations by administering FO daily at a dose of 30 mg kg⁻¹. Alone, LPS elevated the level of C-reactive protein by more than 500% and free radicals by 36% in plasma, as indicated by an increased level of malondialdehyde. The Na, K-ATPase was slightly altered in the vicinity of the ATP-binding site as suggested by the 9% increase of the concentration of ATP necessary for half-maximal activation of the enzyme, thus indicating a deteriorated binding of ATP as a consequence of inflammation. Daily supplementation of FO partly attenuated LPS-induced injury, as observed by a significant decrease in the plasma levels of C-reactive protein and free radicals, hence maintaining the activity of renal Na, K-ATPase to the level of healthy control animals. In conclusion, our findings showed that FO prevented an excessive malondialdehyde production in LPS-treated animals and stabilized renal Na, K-ATPase.


Subject(s)
Dietary Supplements , Fatty Acids, Omega-3/administration & dosage , Kidney/drug effects , Lipopolysaccharides/adverse effects , Sodium-Potassium-Exchanging ATPase/metabolism , Animals , Blood Pressure/drug effects , Body Weight/drug effects , C-Reactive Protein/metabolism , Fish Oils/administration & dosage , Heart Rate/drug effects , Inflammation/drug therapy , Kidney/enzymology , Male , Malondialdehyde/blood , Organ Size/drug effects , Rats , Rats, Wistar , Sodium/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...